Liu Shen Assisted CANbridge To Be Listed on HKEX

Author: | UpdateTime:2021-12-10 | Hits:

On December 10, 2021, CANbridge Pharmaceuticals, Inc.  (“CANbridge”) (Stock Code: 01228.HK) was officially listed on the Stock Exchange of Hong Kong Limited.  Morgan Stanley and Jefferies Financial Group Co., Ltd. acted as co-sponsors for this issuance.

Established in 2012, CANbridge is a rare disease-focused innovative pharmaceutical company committed to the development and commercialization of therapeutics for rare diseases and rare oncology.

As the intellectual property legal consultant for this listing of CANbridge, Liu Shen & Associates provided a full range of intellectual property legal services for this project, with the attorney team including Dr. Stephen Zou and Dr. Liu Guojun as the signing attorneys, and Dr. Tu Tao, Dr. Zhang Yuan and etc. as project participants.